CNS Orphan Diseases - the alternative route in CNS
09 Apr 2013 - 09 Apr 2013 - London, UK
The challenges of drug development in CNS is well known, the recent failures of the large phase III trials in Alzheimer's disease illustrates the problem. There is however an alternative route in CNS which can prove to be more accesible to small and medium sized companies, and that is CNS Orphan diseases. Diseases such as Progressive supraneuclear Palsy (PSP), Fronto Temporal Dementia (FTD) or Huntington's disease can be initial substitutes for the likes of Alzheimer's disease or Parkinson's disease in which to test the effectiveness of a drug.